Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) SHZ

13.13

+0.06(+0.46%)

Updated at September 08 03:04PM

Currency In CNY

Valuation

Market Cap15.69B
Enterprise Value16.97B
P/E Ratio47.58
PEG Ratio-1.26
Price/Sales Ratio3.34
Price/Book Ratio1.58
Enterprise/Revenue3.38
Enterprise/EBITDA32.68

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.08

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue5.28B
Revenue/Share3.59
Gross Profit1.76B
EBITDA1.2B
Net Income646.74M
Diluted EPS0.44

Balance Sheet

Total Cash3.06B
Total Cash/Share2.09
Total Debt2.37B
Total Debt/Equity0.19
Current Ratio2.29
Book Value Per Share8.32

Price History

52-Week Change34.39
52-Week High14.34
52-Week Low9.01
Moving Average 50 Days12.9
Moving Average 200 Days11.54

Statistics

Average Volume7.64M
Shares Outstanding1.34B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield1.9
Payout Ratio0.28
Last Split Factor8:5
Last Split DateJune 13, 2016